Corvus Pharmaceuticals (CRVS)
Corvus Pharmaceuticals (CRVS) stock research: performance, analysts' price targets, earnings, revenue and margins, technicals and insider trades.
- CRVS last traded at $9.67 on 2026-11-20, -3.40% for the session.
- Corvus Pharmaceuticals: market cap $815.69M.
- Over the past year CRVS returned 8.65%, with a year-to-date return of 25.58%.